AIM Capital Surpluse vs Total Liab Analysis

0A4Y Stock   0.22  0.01  4.35%   
AIM ImmunoTech financial indicator trend analysis is way more than just evaluating AIM ImmunoTech prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether AIM ImmunoTech is a good investment. Please check the relationship between AIM ImmunoTech Capital Surpluse and its Total Liab accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AIM ImmunoTech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more information on how to buy AIM Stock please use our How to Invest in AIM ImmunoTech guide.

Capital Surpluse vs Total Liab

Capital Surpluse vs Total Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of AIM ImmunoTech Capital Surpluse account and Total Liab. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between AIM ImmunoTech's Capital Surpluse and Total Liab is -0.12. Overlapping area represents the amount of variation of Capital Surpluse that can explain the historical movement of Total Liab in the same time period over historical financial statements of AIM ImmunoTech, assuming nothing else is changed. The correlation between historical values of AIM ImmunoTech's Capital Surpluse and Total Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capital Surpluse of AIM ImmunoTech are associated (or correlated) with its Total Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Liab has no effect on the direction of Capital Surpluse i.e., AIM ImmunoTech's Capital Surpluse and Total Liab go up and down completely randomly.

Correlation Coefficient

-0.12
Relationship DirectionNegative 
Relationship StrengthInsignificant

Capital Surpluse

Total Liab

The total amount of all liabilities that a company has, including both short-term and long-term liabilities.
Most indicators from AIM ImmunoTech's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into AIM ImmunoTech current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AIM ImmunoTech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more information on how to buy AIM Stock please use our How to Invest in AIM ImmunoTech guide.Selling General Administrative is likely to drop to about 8 M in 2024

AIM ImmunoTech fundamental ratios Correlations

-0.781.0-0.821.0-0.71.0-0.660.91-0.63-0.140.990.890.76-0.880.02-0.871.0-0.950.70.83-0.71-0.63
-0.78-0.790.62-0.750.28-0.790.2-0.70.430.38-0.78-0.73-0.740.65-0.240.84-0.770.77-0.41-0.510.410.43
1.0-0.79-0.81.0-0.71.0-0.660.91-0.62-0.20.990.880.78-0.86-0.01-0.860.99-0.940.660.8-0.67-0.62
-0.820.62-0.8-0.830.52-0.830.54-0.760.28-0.11-0.83-0.82-0.550.9-0.210.88-0.830.9-0.81-0.870.870.28
1.0-0.751.0-0.83-0.731.0-0.70.92-0.61-0.140.990.890.78-0.89-0.02-0.861.0-0.940.70.83-0.71-0.61
-0.70.28-0.70.52-0.73-0.690.87-0.610.40.07-0.64-0.56-0.570.510.350.41-0.730.53-0.43-0.50.450.4
1.0-0.791.0-0.831.0-0.69-0.650.92-0.61-0.140.990.90.76-0.890.04-0.881.0-0.960.710.83-0.72-0.61
-0.660.2-0.660.54-0.70.87-0.65-0.60.370.11-0.65-0.52-0.650.590.540.32-0.680.53-0.37-0.550.370.37
0.91-0.70.91-0.760.92-0.610.92-0.6-0.44-0.120.910.980.79-0.930.04-0.860.92-0.910.820.91-0.75-0.44
-0.630.43-0.620.28-0.610.4-0.610.37-0.44-0.23-0.64-0.32-0.230.43-0.230.48-0.60.57-0.29-0.370.341.0
-0.140.38-0.2-0.11-0.140.07-0.140.11-0.12-0.23-0.11-0.12-0.59-0.090.63-0.07-0.13-0.050.370.19-0.44-0.23
0.99-0.780.99-0.830.99-0.640.99-0.650.91-0.64-0.110.880.75-0.910.05-0.880.99-0.970.710.84-0.72-0.64
0.89-0.730.88-0.820.89-0.560.9-0.520.98-0.32-0.120.880.77-0.940.11-0.890.9-0.910.860.92-0.8-0.32
0.76-0.740.78-0.550.78-0.570.76-0.650.79-0.23-0.590.750.77-0.68-0.37-0.590.77-0.660.360.55-0.28-0.23
-0.880.65-0.860.9-0.890.51-0.890.59-0.930.43-0.09-0.91-0.94-0.68-0.170.9-0.890.96-0.88-0.970.860.43
0.02-0.24-0.01-0.21-0.020.350.040.540.04-0.230.630.050.11-0.37-0.17-0.440.02-0.250.380.19-0.44-0.23
-0.870.84-0.860.88-0.860.41-0.880.32-0.860.48-0.07-0.88-0.89-0.590.9-0.44-0.880.96-0.82-0.840.830.48
1.0-0.770.99-0.831.0-0.731.0-0.680.92-0.6-0.130.990.90.77-0.890.02-0.88-0.950.720.83-0.73-0.6
-0.950.77-0.940.9-0.940.53-0.960.53-0.910.57-0.05-0.97-0.91-0.660.96-0.250.96-0.95-0.83-0.910.840.57
0.7-0.410.66-0.810.7-0.430.71-0.370.82-0.290.370.710.860.36-0.880.38-0.820.72-0.830.96-0.98-0.29
0.83-0.510.8-0.870.83-0.50.83-0.550.91-0.370.190.840.920.55-0.970.19-0.840.83-0.910.96-0.93-0.37
-0.710.41-0.670.87-0.710.45-0.720.37-0.750.34-0.44-0.72-0.8-0.280.86-0.440.83-0.730.84-0.98-0.930.34
-0.630.43-0.620.28-0.610.4-0.610.37-0.441.0-0.23-0.64-0.32-0.230.43-0.230.48-0.60.57-0.29-0.370.34
Click cells to compare fundamentals

AIM ImmunoTech Account Relationship Matchups

AIM ImmunoTech fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets14.2M13.8M20.8M64.6M74.3M78.0M
Total Current Liabilities5.3M1.1M1.1M673K605.7K575.4K
Total Stockholder Equity8.7M5.2M13.4M61.3M70.5M74.0M
Retained Earnings(318.6M)(327.6M)(342.0M)(361.1M)(325.0M)(341.2M)
Cash1.4M299K1.5M38.5M44.3M46.5M
Other Assets1.4M1.9M748K1.3M1.2M1.1M
Cash And Short Term Investments2.1M1.8M8.8M39.0M44.9M47.1M
Short Term Investments695K1.5M7.3M501K576.2K547.3K
Capital Surpluse317.4M323.7M340.2M402.5M462.9M374.0M
Total Liab5.5M8.7M7.3M3.3M3.8M6.2M
Total Current Assets3.8M10.4M40.3M50.2M57.7M60.6M
Intangible Assets858K912K1.2M1.5M1.7M1.2M
Common Stock1K10K42K48K55.2K29.0K
Property Plant Equipment7.8M7.3M6.7M4.2M3.8M5.9M
Other Liab1.1M57K180K35K31.5K29.9K
Net Tangible Assets4.3M11.5M59.1M54.2M62.3M65.4M
Accounts Payable680K472K383K198K178.2K169.3K
Net Receivables1.1M820K1.1M1.6M1.9M1.0M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for AIM Stock Analysis

When running AIM ImmunoTech's price analysis, check to measure AIM ImmunoTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AIM ImmunoTech is operating at the current time. Most of AIM ImmunoTech's value examination focuses on studying past and present price action to predict the probability of AIM ImmunoTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AIM ImmunoTech's price. Additionally, you may evaluate how the addition of AIM ImmunoTech to your portfolios can decrease your overall portfolio volatility.